FITZGERALD, Ga., Feb. 14, 2017 -- Colony Bankcorp, Inc. (Nasdaq:CBAN) announced today that its Board of Directors declared a quarterly cash dividend of $0.025 per share payable March 31, 2017 to shareholders of record on March 1, 2017. The board factored in earnings projected for the quarter along with Colony’s capital position in setting the dividend payment. Colony’s capital position remains strong with its total risk-based capital approximating 16.50 percent – well above the regulatory minimum requirement of 10 percent to be categorized as “well-capitalized.” “Much progress has been made by Colony since we last paid dividends in June 2009. While we have been focused on reducing our outstanding preferred stock the past couple of years, we are pleased to reward our shareholders with the reinstatement of cash dividends,” said Ed Loomis, President and Chief Executive Officer.
Colony Bankcorp, Inc. is a bank holding company headquartered in Fitzgerald, Georgia with twenty-eight offices located in central, southern and coastal Georgia cities of Albany, Ashburn, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, Leesburg, Moultrie, Quitman, Rochelle, Savannah, Soperton, Statesboro, Sylvester, Thomaston, Tifton, Valdosta and Warner Robins, Georgia. Total consolidated assets of the company approximate $1.20 billion.
Colony Bankcorp, Inc. Common Stock is quoted on the Nasdaq National Market under the symbol “CBAN.”
Contact: Terry L. Hester Chief Financial Officer Colony Bankcorp, Inc. Fitzgerald, GA 31750 (229) 426-6000 (ext. 6002)


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



